Tuberculous meningitis (TBM) results in considerable morbidity and mortality, especially in developing countries such as South Africa. Treatment regimens have been extrapolated from treatment for pulmonary tuberculosis, and the intensive-phase duration of 2 months may be inadequate for treatment of patients with TBM. We highlight this situation with a case report of a patient with TBM whose illness progressed after institution of the maintenance phase of treatment. We propose that the intensive-phase treatment of TBM be revisited with regard to duration of treatment, choice of drugs during continuation-phase therapy, or both
A total of 215 patients with tuberculous meningitis were treated for nine months with one of the fol...
A total of 215 patients with tuberculous meningitis were treated for nine months with one of the fol...
PURPOSE OF REVIEW: Tuberculous meningitis (TBM) is a global health problem. In this review, we syste...
Tuberculous meningitis (TBM) is a medical emergency for which tuberculosis (TB) treatment should be ...
BACKGROUND: Tuberculous meningitis is often lethal. Early antituberculosis treatment and adjunctive ...
Tuberculous meningitis (TBM) is a frequent cause of meningitis in South Africa (SA) and has a dismal...
Background: The duration of anti-tuberculous therapy in tuberculous meningitis is controversial. The...
Tuberculous meningitis (TBM) results from dissemination of M. tuberculosis to the cerebrospinal flui...
Tuberculous meningitis (TBM) is caused by Mycobacterium tuberculosis and kills or disables around a ...
CITATION: Marais, S., et al. 2019. Management of intracranial tuberculous mass lesions : how long sh...
Introduction: Tubercular meningitis (TBM) is a common cause of chronic meningitis in India; however,...
Tuberculous intracranial mass lesions are common in settings with high tuberculosis (TB) incidence a...
Tuberculous intracranial mass lesions are common in settings with high tuberculosis (TB) incidence a...
Notwithstanding available diagnosis and treatment, tuberculosis (TB) is the most persistent pandemic...
International audienceBACKGROUND: Tuberculous meningitis (TBM) is the most lethal and disabling form...
A total of 215 patients with tuberculous meningitis were treated for nine months with one of the fol...
A total of 215 patients with tuberculous meningitis were treated for nine months with one of the fol...
PURPOSE OF REVIEW: Tuberculous meningitis (TBM) is a global health problem. In this review, we syste...
Tuberculous meningitis (TBM) is a medical emergency for which tuberculosis (TB) treatment should be ...
BACKGROUND: Tuberculous meningitis is often lethal. Early antituberculosis treatment and adjunctive ...
Tuberculous meningitis (TBM) is a frequent cause of meningitis in South Africa (SA) and has a dismal...
Background: The duration of anti-tuberculous therapy in tuberculous meningitis is controversial. The...
Tuberculous meningitis (TBM) results from dissemination of M. tuberculosis to the cerebrospinal flui...
Tuberculous meningitis (TBM) is caused by Mycobacterium tuberculosis and kills or disables around a ...
CITATION: Marais, S., et al. 2019. Management of intracranial tuberculous mass lesions : how long sh...
Introduction: Tubercular meningitis (TBM) is a common cause of chronic meningitis in India; however,...
Tuberculous intracranial mass lesions are common in settings with high tuberculosis (TB) incidence a...
Tuberculous intracranial mass lesions are common in settings with high tuberculosis (TB) incidence a...
Notwithstanding available diagnosis and treatment, tuberculosis (TB) is the most persistent pandemic...
International audienceBACKGROUND: Tuberculous meningitis (TBM) is the most lethal and disabling form...
A total of 215 patients with tuberculous meningitis were treated for nine months with one of the fol...
A total of 215 patients with tuberculous meningitis were treated for nine months with one of the fol...
PURPOSE OF REVIEW: Tuberculous meningitis (TBM) is a global health problem. In this review, we syste...